Development of a population-based questionnaire to explore psychosocial determinants of screening for memory loss and Alzheimer disease

Alzheimer Disease and Associated Disorders

Volumn 20, Issue 3, 2006, Pages 182-191

  Galvin, James E ^a   Scharff, Darcell P ^b   Glasheen, Cristie ^b   Fu, Qiang ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Dementia; Health services use; Screening

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BEHAVIORAL MODEL OF HEALTH SERVICES USE; COGNITIVE DEFECT; CONCEPTUAL FRAMEWORK; CONSTRUCT VALIDITY; CRONBACH ALPHA COEFFICIENT; EVALUATION; FACTORIAL ANALYSIS; FEMALE; HEALTH BELIEF; HEALTH BELIEF MODEL; HEALTH CARE UTILIZATION; HUMAN; INTERNAL CONSISTENCY; LANGUAGE; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SCREENING; SELF CONCEPT; SOCIAL ASPECT; SOCIOECONOMICS; THEORY OF REASONED ACTION; UNITED STATES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAUSALITY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; MALE; MASS SCREENING; MEMORY DISORDERS; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF CONCEPT;

EID: 33747497781     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200607000-00010     Document Type: Article

References (64)

1. Agency for Healthcare Research and Quality. Early Alzheimer's disease: recognition and assessment. Guideline Overview No. 19. Available at: www.ahcpr.gov/clinic/alzover.htm. Accessed 1/10/05.
2. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease. Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 1998;55:326-335.
3. Galvin JE, Powlishta KK, Wilkins K, et al. Predictors of preclinical Alzheimer's disease and dementia: a clinicopathologic study. Arch Neurol. 2005;62:758-765.
4. Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119-1122.
5. Jorm A, Jolley D. The incidence of dementia: a meta-analysis. Neurology. 1998;51:728-733.
6. Petersen RC, Doody R, Kurz A et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
7. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397-405.
8. Galvin JE, Roe CM, Powlishta KK, et al. The AD8: a brief informant interview to detect dementia. Neurology. 2005;65:559-564.
9. Csernansky JG, Wang L, Swank J, et al. Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly. Neuroimage. 2005;25:783-792.
10. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306-319.
11. Han X, Fagan AM, Cheng H, et al. Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Ann Neurol. 2003;54:115-119.
12. Cochrane AL, Holland WW. Validation of screening procedures. Br Med Bull. 1971;27:3-8.
13. Boustani M, Watson L, Fultz B, et al. Acceptance of dementia screening in continuous care retirement communities: a mailed survey. Int J Geriatr Psych. 2003;18:780-786.
14. Werner P. Factors influencing intentions to seek a cognitive status examination: a study based on the Health Belief Model. Int J Geriatr Psych. 2003;18:787-794.
15. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36:1-10.
16. Zapka JG, Taplin SH, Solberg LI, et al. A framework for improving the quality of cancer care: the case of breast and cervical cancer screening. Cancer Epidemiol Biomarkers Prev. 2003;12:4-13.
17. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice Hall; 1980.
18. Montano DE, Kasprzyk D. The theory of reasoned action and the theory of planned behavior. In: Glanz K, Rimer BK, Lewis FM, eds. Health Behavior and Health Education. 3rd ed. San Francisco, CA: Jossey-Bass; 2002:85-113.
19. Frost S, Myers LB, Newman SP. Genetic screening for Alzheimer's disease: what factors predict intentions to take a test? Behav Med. 2001;27:101-109.
20. Steadman L, Rutter DR. Belief importance and the theory of planned behaviour: comparing modal and ranked modal beliefs in predicting attendance at breast screening. Br J Health Psychol. 2004;9:447-463.
21. Berglund G, Nilsson S, Nordin K. Intention to test for prostate cancer. Eur J Cancer. 2005;41:990-997.
22. Hou SI. Factors associated with intentions for colorectal cancer screenings in a Chinese sample. Psychol Rep. 2005;96:159-162.
23. Green MJ, Peterson SK, Baker MW, et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. J Am Med Assoc. 2004;292:442-452.
24. Boundouki G, Humphris G, Field A. Knowledge of oral cancer, distress and screening intentions: longer term effects of a patient information leaflet. Patient Educat Counsel. 2004;53:71-77.
25. Hofvind SS, Wang H, Thoresen S. The Norwegian Breast Cancer Screening Program: re-attendance related to the women's experiences, intentions and previous screening result. Cancer Causes Control. 2003;14: 391-398.
26. Humphris GM, Field EA. The immediate effect on knowledge, attitudes and intentions in primary care attenders of a patient information leaflet: a randomized control trial replication and extension. Br Dental J. 2003;194: 683-688.
27. Kahn JA, Goodman E, Slap GB, et al. Intention to return for papanicolaou smears in adolescent girls and young women. Pediatrics. 2001;108:333-341.
28. Nordin K, Bjork J, Berglund G. Factors influencing intention to obtain a genetic test for a hereditary disease in an affected group and in the general public. Prev Med. 2004;39:1107-1114.
29. Kessler L, Collier A, Brewster K, et al. Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Am College Med Genetics. 2005;7:230-238.
30. Bunn JY, Bosompra K, Ashikaga T, et al. Factors influencing intention to obtain a genetic test for colon cancer risk: a population-based study. Prev Med. 2002;34:567-577.
31. Fernandez MI, Collazo JB, Bowen GS, et al. Predictors of HIV testing and intention to test among Hispanic farmworkers in South Florida. J Rural Health. 2005;21:56-64.
32. Hou SI, Wisenbaker J. Using a web-based survey to assess correlates of intention towards HIV testing among never-been-tested but sexually experienced college students. AIDS Care. 2005;17:329-334.
33. Van Voorhees BW, Fogel J, Houston TK, et al. Beliefs and attitudes associated with the intention to not accept the diagnosis of depression among young adults. Ann Fam Med. 2005;3:38-46.
34. Michie S, Dormandy E, Marteau TM. Increasing screening uptake amongst those intending to be screened: the use of action plans. Patient Educ Couns. 2004;55:218-222.
35. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10-24.
36. Hollingshead AB. Four Factor Index of Social Status. New Haven, CT: Yale University; 1975.
37. Elder JP, Ayala GX, Harris S. Theories and intervention approaches to health-behavior change in primary care. Am J Prev Med. 1999;17:275-284.
38. Aben I, Verhey F, Lousberg R, et al. Validity of the Beck Depression Inventory, Hospital Anxiety and Depression Scale, SCL-90, and Hamilton Depression Rating Scale as screening instruments for depression in stroke patients. Psychomsomatics. 2002;43:386-393.
39. Dunbar M, Ford G, Hunt K, Der G. A confirmatory factor analysis of the Hospital Anxiety and Depression scale: comparing empirically and theoretically derived structures. Br J Clin Psychol. 2000;39:79-94.
40. Mykletun A, Stordal E, Dahl A. Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population. Br J Psych. 2001;179:540-544.
41. Lasher KP, Faulkender PJ. Measurement of aging anxiety: development of the Anxiety about Aging Scale. Inter J Aging Hum Dev. 1993;37:247-259.
42. Watkins RE, Coates R, Ferroni P. Measurement of aging anxiety in an elderly Australian population. Inter J Aging Hum Dev. 1998;46:319-332.
43. Pearman A, Storandt M. Self-discipline and self-consciousness predict subjective memory in older adults. J Gerontol B Psychol Sci Soc Sci. 2005;60:153-157.
44. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism form neuroticism (and trait anxiety, self-master, and self-esteem): a re-evaluation of the Life Orientation Test. J Personality Soc Psychol. 1994;67:1063-1078.
45. Nelson DE, Holtzman D, Bolen J, et al. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soz Praventivmed. 2004;46(suppl 1):S3-42.
46. Kinney AY, Bloor LE, Martin C, Sandler RS. Social ties and colorectal cancer screening among Blacks and Whites in North Carolina. Cancer Epidemiol Biomarkers Prev. 2005;14:182-189.
47. Berkman LF, Glass T. Social integration, social networks, social support, and health. In: Berkman LF, Kawachi I, eds. Social Epidemiology. New York, NY: Oxford Press; 2000.
48. Heaney CA, Israel BA. Social networks and social support. In: Glanz K, Rimer BK, Lewis FM, eds. Health Behavior and Health Education. 3rd ed. San Francisco, CA: Jossey-Bass; 2002.
49. Sherbourne CD, Stewart AL. The MOS social support survey. Social Sci Med. 1991;32:705-714.
50. Sarason IG, Sarason BR, Edward N, et al. A brief measure of social support: practical and theoretical implications. J Social Personal Relationship. 1987;4:497-510.
51. Aday LA, Andersen R. A framework for the study of access to medical care. Health Services Res. 1974;9:208-220.
52. Goldberg DP, Gater R, Sartorius N, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27:191-197.
53. Papassotiropoulos A, Heun R, Maier W. Age and cognitive impairment influence the performance of the General Health Questionnaire. Compr Psychiatry. 1997;38:335-340.
54. Logsdon RG, Gibbons LE, McCurry SM, et al. Assessing quality of life in older adults with cognitive impairment. Psychosom Med. 2002;64:510-519.
55. Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31:143-164.
56. Kawas C, Karagiozis H, Resau L, et al. Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol. 1995;8:238-242.
57. Jobe JB, Mingay DJ. Cognitive laboratory approach to designing questionnaires for surveys of the elderly. Public Health Rep. 1990;105:518-524.
58. Wang L, van Belle G, Crane PK, et al. Subjective memory deterioration and future dementia in people aged 65 and older. J Am Geriatr Soc. 2004;52:2045-2051.
59. Campbell MK, Symons M, Demark-Wahnefried W, et al. Stages of change and psychosocial correlates of fruit and vegetable consumption among rural African-American church members. Am J Health Promot. 1998;12:185-191.
60. Scherl WF, Krupp LB, Christodoulou C, et al. Normative data for the selective reminding test: a random digit dialing sample. Psychol Rep. 2004;95:593-603.
61. Potthoff RF. Telephone sampling in epidemiologic research: to reap the benefits, avoid the pitfalls. Am J Epidemiol. 1994;139:967-978.
62. Neumann PJ, Hammitt JK, Mueller C, et al. Public attitudes about genetic testing for Alzheimer's disease. Health Affairs. 2001;20:252-264.
63. Funkhouser E, Macaluso M, Wang X. Alternative strategies for selecting population controls: comparison of random digit dialing and targeted telephone calls. Ann Epidemiol. 2000;10:59-67.
64. Keefover RW, Rankin ED, Keyl PM, et al. Dementing illnesses in rural populations: the need for research and challenges confronting investigators. J Rural Health. 1996;12:178-187.